Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 2Phase 2/3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Pain 1Neoplasms 1Intestinal Obstruction 1Constipation 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Naloxone × Clear all
NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT00020605 2018-12-13

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

National Cancer Institute (NCI)

Phase 3 Unknown
Other

Constipation, Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡